Literature DB >> 22705017

Increased risk of chronic kidney disease among users of non-prescribed Chinese herbal medicine in Taiwan.

Chuan-Fa Hsieh1, Song-Lih Huang, Chien-Lung Chen, Wei-Ta Chen, Huan-Cheng Chang, Ming-Ling Wu, Chen-Chang Yang.   

Abstract

BACKGROUND: Taiwan has the highest incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide. Chinese herbal medicine (CHM) has been linked to CKD/ESRD in Taiwan. The specific effects and frequency of CHM on the risk of CKD are unknown.
METHODS: A hospital-based case-control study was performed from August 2006 through December 2009. The cases were consecutive nephrology outpatients 20years of age or older, with a first-time diagnosis of CKD, and without cancer or pre-existing renal disease. The controls were randomly selected outpatients that did not have CKD and were matched 1:1 to cases for age, gender and date of outpatient visit.
RESULTS: Four hundred and twenty-four patients were recruited. Among 212 cases, 23.6% took non-prescribed CHM, compared to 6.6% among the controls (p<0.001). Multivariate analysis showed that illiteracy [odds ratio (OR) 6.3, 95% confidence interval (CI) 2.4-16.6], hypertension (OR 5.4, 95% CI 2.9-9.8) and occasional use of non-prescribed CHM (OR 6.2, 95% CI 1.8-21.6) were positively associated with CKD, whereas regular exercise was inversely associated with CKD (OR 0.5, 95% CI 0.3-0.9).
CONCLUSION: Occasional use of non-prescribed CHM was associated with the risk of CKD in Taiwan.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22705017     DOI: 10.1016/j.ypmed.2012.06.003

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  10 in total

1.  A case of renal failure developing in association with African mango consumption.

Authors:  Gülsüm Özkan; Şükrü Ulusoy
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Non-aristolochic acid prescribed Chinese herbal medicines and the risk of mortality in patients with chronic kidney disease: results from a population-based follow-up study.

Authors:  Chuan Fa Hsieh; Song Lih Huang; Chien Lung Chen; Wei Ta Chen; Huan Cheng Chang; Chen Chang Yang
Journal:  BMJ Open       Date:  2014-02-21       Impact factor: 2.692

3.  Addressing health disparities in chronic kidney disease.

Authors:  Ta-Chien Chan; I-Chun Fan; Michael Shi-Yung Liu; Ming-Daw Su; Po-Huang Chiang
Journal:  Int J Environ Res Public Health       Date:  2014-12-11       Impact factor: 3.390

Review 4.  Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture.

Authors:  Keryn G Woodman; Chantal A Coles; Shireen R Lamandé; Jason D White
Journal:  Nutrients       Date:  2016-11-09       Impact factor: 5.717

5.  Prescribed Renoprotective Chinese Herbal Medicines Were Associated with a Lower Risk of All-Cause and Disease-Specific Mortality among Patients with Chronic Kidney Disease: A Population-Based Follow-Up Study in Taiwan.

Authors:  Chuan-Fa Hsieh; Huan-Cheng Chang; Song-Lih Huang; Chien-Lung Chen; Wei-Ta Chen; Chen-Chang Yang
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-17       Impact factor: 2.629

6.  Association of non-allopathic drugs and dietary factors with chronic kidney disease: A matched case-control study in South India.

Authors:  Sujiv Akkilagunta; K C Premarajan; Sreejith Parameswaran; Sitanshu Sekhar Kar
Journal:  J Family Med Prim Care       Date:  2018 Nov-Dec

7.  The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics.

Authors:  Vivek Kumar; Ashok Kumar Yadav; Jasmine Sethi; Arpita Ghosh; Manisha Sahay; Narayan Prasad; Santosh Varughese; Sreejith Parameswaran; Natarajan Gopalakrishnan; Prabhjot Kaur; Gopesh K Modi; Kajal Kamboj; Monica Kundu; Vivek Sood; Neeraj Inamdar; Ajay Jaryal; Sanjay Vikrant; Saurabh Nayak; Shivendra Singh; Sishir Gang; Seema Baid-Agrawal; Vivekanand Jha
Journal:  Clin Kidney J       Date:  2021-08-13

8.  Facilitators and barriers of herbal medicine use in Accra, Ghana: an inductive exploratory study.

Authors:  Lydia Aziato; Hannah Ohemeng Antwi
Journal:  BMC Complement Altern Med       Date:  2016-05-26       Impact factor: 3.659

Review 9.  Preventing CKD in Developed Countries.

Authors:  Valerie A Luyckx; David Z I Cherney; Aminu K Bello
Journal:  Kidney Int Rep       Date:  2019-12-18

Review 10.  Review of Traditional Chinese Medicines for Common Complications Related to Hemodialysis: An Evidence-Based Perspective.

Authors:  Yan-Wen Liu; Yung-Tang Hsu; Wen-Chin Lee; Ming-Yen Tsai
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-13       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.